Диссертация (1139652), страница 31
Текст из файла (страница 31)
[et al.] // Am J Obstet Gynecol. 2010. – Vol. 203,№5. – P.1-5.252. The prevalence of extraintestinal diseases in inflammatory bowel disease: apopulation-based study / C.N. Bernstein [et al.] // Am J Gastroenterol. – 2001.- № 96. - 1116–1122.253. The TGR5 receptor mediates bile acid-induced itch and analgesia / F. Alemi[et al.] // J Clin Invest. - 2013. - №123. – P.1513-1530.254.
The wide spectrum of multidrug resistance 3 deficiency: from neonatalcholestasis to cirrhosis of adulthood / E. Jacquemin [et al.]//Gastroenterology. – 2001. - №120, №6. – P.1448-1458.255. Thijs C. Oral contraceptives and the risk of gallbladder disease: a metaanalysis / C. Thijs, P. Knipschild // Am J Public Health.
– 1993. - №83. –P.1113-1120.256. Thijs C. Pregnancy and gallstone disease: an empiric demonstration of theimportance of specification of risk periods / C.Thijs, P.Knipschild, P. Leffers// Am J Epidemiol. – 1991. - №134. – P.186-195.257. Thornton JGPITCH Study Consortium. Ursodeoxycholic acid versusplacebo, and early term delivery versus expectant management, in women withintrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial /L.C.Chappell[etal.]// BMJ.-2012;344:e3799.doi:10.1136/bmj.e379922695903.258.
Treatment of psoriasis and psoriatic arthritis during pregnancy andbreastfeeding / P.S. Kurizky [et al.] // Anais Brasileiros de Dermatologia. –2015. – Vol. 90. №3. – P.367-375.203259. Turley S.D. The contribution of newly synthesized cholesterol to biliarycholesterol in the rat / S.D. Turley, J.M. Dietschy // J Biol Chem. – 1981. №256.
– P. 2438–2446.260. Ursodeoxycholic acid administration in patients with cholestasis ofpregnancy: effects on primary bile acids in babies and mothers / G. Mazzella[et al.] // Hepatology. – 2001. - №33. – P. 504–508.261. Ursodeoxycholic acid and S-adenosylmethionine for the treatment ofintrahepatic cholestasis of pregnancy: a meta-analysis / Y. Zhang [et al.] //Hepat Mon.
– 2016. 16:e38558. doi:10.5812/hepatmon.3855827799965.262. Variations of ABCB4 and ABCB11 genes are associated with primaryintrahepatic stones / S.Pan [et al.] // Mol Med Rep. – 2015. – Vol.11, №1. –P. 434-446. doi: 10.3892/mmr.2014.2645. Epub 2014 Oct 15.263. Wang H.H. Overexpression of estrogen receptor alpha increases hepaticcholesterogenesis, leading to biliary hypersecretion in mice / H.H.Wang,N.H.Afdhal, D.Q.Wang // J Lipid Res.- 2006. – №47. – P.778-786.264. Williamson C.
Intrahepatic cholestasis of pregnancy / C.Williamson,V.Geenes // Obstet Gynecol. – 2014. – Vol.124, №1. – P.120-133.265. Winbery S.L. Dyspepsia in pregnancy / S.L.Winbery , K.E. Blaho // ObstetGynecol Clin North Am. – 2001. – Vol.28, №2. – P. 333-350.266. Yimam K.K. Diagnosis and classification of primary sclerosing cholangitis/ K.K.Yimam, C.L. Bowlus // Autoimmun Rev. – 2014. - №13. –P.445–450.267.
Yu L. Relationship between total bile acid concentration and fetal pulmonarysurfactant in intrahepatic cholestasis of pregnancy / L.Yu, Y.L.Ding, C.X. //Wang Zhonghua Fu Chan Ke Za Zhi. – 2011. - №46, №5. – P.324-328.268. Zimmerman H.J. Hepatotoxicity: The Adverse Effects of Drugs and OtherChemicals on the Liver / H.J. Zimmerman. - Philadelphia, USA: LippincottWilliams & Wilkins. – 1999.
– P.789..